239 related articles for article (PubMed ID: 9177828)
1. Prevalence of anti-varicella zoster IgG antibody in undergraduate students.
Bhattarakosol P; Chantarabul S; Pittayathikhun K; Mung-mee V; Punnarugsa V
Asian Pac J Allergy Immunol; 1996 Dec; 14(2):129-31. PubMed ID: 9177828
[TBL] [Abstract][Full Text] [Related]
2. Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virus-specific immunoglobulin M, A and G in patients with varicella or herpes zoster.
van Loon AM; van der Logt JT; Heessen FW; Heeren MC; Zoll J
Epidemiol Infect; 1992 Feb; 108(1):165-74. PubMed ID: 1312479
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of varicella-zoster virus in Korea.
Choi WS; Noh JY; Huh JY; Jo YM; Lee J; Song JY; Kim WJ; Cheong HJ
J Med Virol; 2010 Dec; 82(12):2123-6. PubMed ID: 20981803
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity.
Heininger U; Braun-Fahrländer C; Desgrandchamps D; Glaus J; Grize L; Wutzler P; Schaad UB;
Pediatr Infect Dis J; 2001 Aug; 20(8):775-8. PubMed ID: 11734740
[TBL] [Abstract][Full Text] [Related]
5. A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil.
Semenovitch I; Lupi O
Int J Dermatol; 2003 Mar; 42(3):193-6. PubMed ID: 12653913
[TBL] [Abstract][Full Text] [Related]
6. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
Sauerbrei A; Wutzler P
J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
[TBL] [Abstract][Full Text] [Related]
7. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
[TBL] [Abstract][Full Text] [Related]
8. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.
Prelog M; Schönlaub J; Jeller V; Almanzar G; Höfner K; Gruber S; Eiwegger T; Würzner R
Vaccine; 2013 May; 31(20):2420-6. PubMed ID: 23583889
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.
Lafer MM; de Moraes-Pinto MI; Weckx LY
Rev Inst Med Trop Sao Paulo; 2005; 47(3):139-42. PubMed ID: 16021286
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of varicella-zoster virus infection in normal healthy individuals aged above 6 months.
Kowitdamrong E; Pancharoen C; Thammaborvorn R; Bhattarakosol P
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S7-11. PubMed ID: 16622994
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity.
Rondaan C; van Leer CC; van Assen S; Bootsma H; de Leeuw K; Arends S; Bos NA; Westra J
Lupus; 2018 Jul; 27(8):1271-1278. PubMed ID: 29667858
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
Heininger U; Desgrandchamps D; Schaad UB
Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
[TBL] [Abstract][Full Text] [Related]
13. Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines.
Kopylov U; Levin A; Mendelson E; Dovrat S; Book M; Eliakim R; Ben-Horin S
Aliment Pharmacol Ther; 2012 Jul; 36(2):145-50. PubMed ID: 22612376
[TBL] [Abstract][Full Text] [Related]
14. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
Sauerbrei A; Wutzler P
Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
[TBL] [Abstract][Full Text] [Related]
15. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.
Wu MF; Yang YW; Lin WY; Chang CY; Soon MS; Liu CE
J Hosp Infect; 2012 Feb; 80(2):162-7. PubMed ID: 22188630
[TBL] [Abstract][Full Text] [Related]
16. Enzyme-linked immunosorbent assay for detection of antibodies to varicella zoster virus.
Goldberg RD; Sarov I
Isr J Med Sci; 1980 Feb; 16(2):111-7. PubMed ID: 6245042
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis.
Manouchehrinia A; Tanasescu R; Kareem H; Jerca OP; Jabeen F; Shafei R; Breuer J; Neal K; Irving W; Constantinescu CS
J Neurovirol; 2017 Dec; 23(6):839-844. PubMed ID: 28895088
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studies.
Talukder Y; Gopal R; Andrews N; Glenn M; Breuer J; Brown D
J Virol Methods; 2005 Sep; 128(1-2):162-7. PubMed ID: 15961168
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to varicella-zoster virus in applicants for nurse training in Scotland.
Waclawski ER; Stewart M
Commun Dis Public Health; 2002 Sep; 5(3):240-2. PubMed ID: 12434695
[TBL] [Abstract][Full Text] [Related]
20. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.
Vandersmissen G; Moens G; Vranckx R; de Schryver A; Jacques P
Occup Environ Med; 2000 Sep; 57(9):621-6. PubMed ID: 10935943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
